Company Filing History:
Years Active: 1978-1984
Title: The Innovations of Robert G Strachan
Introduction
Robert G Strachan is a notable inventor based in Warrington, PA (US), recognized for his contributions to the field of neurobiology. With a total of six patents to his name, Strachan has made significant advancements in the development of neurotensin analogs, which have potential implications in various therapeutic areas.
Latest Patents
Strachan's latest patents include "Cyclic octapeptide analogs of neurotensin," which disclose cyclic octapeptide analogs of the tridecapeptide, neurotensin. Another significant patent is "Metabolically protected analogs of neurotensin," which presents metabolically protected linear analogs of the carboxy terminal pentapeptide fragment of the tridecapeptide, neurotensin. These innovations highlight his expertise in peptide chemistry and neurobiology.
Career Highlights
Strachan is currently employed at Merck & Company, Inc., a leading global healthcare company. His work at Merck has allowed him to collaborate with other prominent scientists and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Some of his notable coworkers include Daniel F Veber and Frederick W Holly, who have also made significant contributions to the field. Their collaborative efforts have further advanced the research and development of neurotensin-related therapies.
Conclusion
Robert G Strachan's innovative work in the field of neurobiology, particularly with neurotensin analogs, showcases his dedication to advancing medical science. His contributions continue to influence research and development in the pharmaceutical industry.